by The global healthcare contract research outsourcing market size was valued at US$ 41.5 billion in 2021 and is anticipated to grow US$ 69.2 billion by 2030, registering a CAGR of 5.85% from 2022 to 2030.
The healthcare contract research outsourcing market report covering various industry elements and growth trends helpful for predicting the market’s future.
The study provides a strong base for the healthcare contract research outsourcing market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2030.
This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2030. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the healthcare contract research outsourcing report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the healthcare contract research outsourcing market have been studied and analysed across many developments.
Market Scope
Research Approach
The comprehensive report on the global healthcare contract research outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global healthcare contract research outsourcing market.
It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Key Players
- Advanced Clinical
- Albany Molecular Research, Inc.
- Charles River Laboratories International, Inc.
- Clinipace
- Clintec
- Covance Clinical Biotech
- CTI Clinical Trial & Consulting
- GVK Biosciences Private Limited
- ICON Plc
- IQVIA HOLDINGS INC.
- Jubilant Biosys Ltd.
- KCR S.A.
- Laboratory Corporation of America Holdings
- Medidata Solutions, Inc.
- Olon Ricerca Bioscience
- PAREXEL International Corp.
- Pharmaceutical Product Development, LLC.
- Pharmaron
- Pharm-Olam, LLC
- PRA Health Sciences, Inc.
- PSI CRO AG
- SGS SA
- Sygnature Discovery Limited
- Syneos Health
- SynteractHCR
- Thermo Fisher Scientific Inc.
- Worldwide Clinical Trials
- WuXi AppTec
Market Segmentations
By Type
- Drug Discovery
- Target Validation
- Lead Identification
- Lead Optimization
- Pre-Clinical
- Clinical
- Phase I Trial Services
- Phase II Trial Services
- Phase III Trial Services
- Phase IV Trial Services
By Service
- Clinical Trial Services
- Preclinical
- Clinical
- Regulatory Services
- Clinical Data Management & Biometrics
- Electronic Data Capture
- Electronic Patient Recorded Outcomes
- Others
- Medical Writing
- Pharmacovigilance
- Site Management Protocol
- Others
By Application
- Oncology/Hematology
- Cardiovascular
- Autoimmune/Inflammation
- Central nervous system (CNS)
- Dermatology
- Infectious diseases
- Diabetes
- Pain
- Other
By End Use
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Academic Institutes & Government Organizations
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Healthcare Contract Research Outsourcing Market
5.1. COVID-19 Landscape: Healthcare Contract Research Outsourcing Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Healthcare Contract Research Outsourcing Market, By Type
8.1. Healthcare Contract Research Outsourcing Market, by Type, 2022-2030
8.1.1. Drug Discovery
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Pre-Clinical
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Clinical
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Healthcare Contract Research Outsourcing Market, By Service
9.1. Healthcare Contract Research Outsourcing Market, by Service, 2022-2030
9.1.1. Clinical Trial Services
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Regulatory Services
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Clinical Data Management & Biometrics
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Medical Writing
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Pharmacovigilance
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Site Management Protocol
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Healthcare Contract Research Outsourcing Market, By Application
10.1. Healthcare Contract Research Outsourcing Market, by Application, 2022-2030
10.1.1. Oncology/Hematology
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Oncology/Hematology
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Autoimmune/Inflammation
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Central nervous system (CNS)
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Dermatology
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Infectious diseases
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Diabetes
10.1.7.1. Market Revenue and Forecast (2017-2030)
10.1.8. Pain
10.1.8.1. Market Revenue and Forecast (2017-2030)
10.1.9. Other
10.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Healthcare Contract Research Outsourcing Market, By End Use
11.1. Healthcare Contract Research Outsourcing Market, by End Use, 2022-2030
11.1.1. Pharmaceutical Companies
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Biotechnology Companies
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Medical Device Companies
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Academic Institutes & Government Organizations
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Healthcare Contract Research Outsourcing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.2. Market Revenue and Forecast, by Service (2017-2030)
12.1.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.4. Market Revenue and Forecast, by End Use (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End Use (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.4. Market Revenue and Forecast, by End Use (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End Use (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End Use (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Service (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End Use (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.4. Market Revenue and Forecast, by End Use (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End Use (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End Use (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Service (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End Use (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.4. Market Revenue and Forecast, by End Use (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End Use (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End Use (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Service (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End Use (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Service (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Service (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End Use (2017-2030)
Chapter 13. Company Profiles
13.1. Advanced Clinical
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Albany Molecular Research, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Charles River Laboratories International, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Clinipace
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Clintec
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Covance Clinical Biotech
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. CTI Clinical Trial & Consulting
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. GVK Biosciences Private Limited
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. ICON Plc
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. IQVIA HOLDINGS INC.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global healthcare contract research outsourcing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for healthcare contract research outsourcing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2132
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
